SCHEMBL3011017

SCHEMBL3011017

NS(=O)(=O)N1C=CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL28154462 0.90
Trifluoroacetic Acid SCHEMBL29498756 0.84 CA12 (0.31)
Methylpiperazine SCHEMBL28305707 0.81 KDM4E (0.31)
SCHEMBL26926379 0.78
SCHEMBL11173353 0.76
SCHEMBL12229004 0.76
Hydrochloric Acid SCHEMBL27259613 0.74
Sulfamate SCHEMBL28953816 0.74 CA1 (0.30)
SCHEMBL4614861 0.73
SCHEMBL28347663 0.69 CYP2C9 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025070390-A1 METHOD FOR PRODUCING N-PYRIDYLSULFONAMIDE COMPOUND, PYRIDINE COMPOUND, AND CRYSTAL OF N-PYRIDYLSULFONAMIDE COMPOUND 第一三共株式会社 2025-04-03 WO claimed
EP-2900670-A1 SUBSTITUTED INDAZOL-PYRROLOPYRIMIDINES USEFUL IN THE TREATMENT OF HYPERFOLIFERATIVE DISORDERS Bayer Pharma Aktiengesellschaft (DE) 2015-08-05 EP claimed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 EP disclosed
WO-2025070390-A1 METHOD FOR PRODUCING N-PYRIDYLSULFONAMIDE COMPOUND, PYRIDINE COMPOUND, AND CRYSTAL OF N-PYRIDYLSULFONAMIDE COMPOUND 第一三共株式会社 2025-04-03 WO disclosed
WO-2025070390-A1 METHOD FOR PRODUCING N-PYRIDYLSULFONAMIDE COMPOUND, PYRIDINE COMPOUND, AND CRYSTAL OF N-PYRIDYLSULFONAMIDE COMPOUND 第一三共株式会社 2025-04-03 WO disclosed
US-12065448-B2 Heteroaryl plasma kallikrein inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-08-20 US disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 WO disclosed
WO-2023237015-A1 N-TETRAZOLYL ARYL UREA DERIVATIVES, PREPARATION METHOD THEREFOR, AND USE THEREOF 杭州壹瑞医药科技有限公司 2023-12-14 WO disclosed
WO-2023161316-A1 ZWITTERIONIC ANTIBACTERIAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2023-08-31 WO disclosed
US-20220298176-A1 HETEROARYL PLASMA KALLIKREIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2022-09-22 US disclosed
CN-115010712-A TDO2 inhibitors 基因泰克公司 2022-09-06 CN disclosed
EP-2193127-A1 BENZOTHIAZOLE COMPOUNDS The Walter and Eliza Hall Institute of Medical Research (AU) 2010-06-09 EP disclosed
CN-101490041-A 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation ASTRAZENECA AB (SE) 2009-07-22 CN disclosed
WO-2009039553-A1 BENZOTHIAZOLE COMPOUNDS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2009-04-02 WO disclosed
CN-100343251-C Substituted homopiperidinyl benzimidazole compounds, pharmaceutical compositions containing them, process for preparing them and their use as medicaments JANSSEN PHARMACEUTICA NV (BE) 2007-10-17 CN disclosed
CN-1411460-A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants JANSSEN PHARMACEUTICA NV (BE) 2003-04-16 CN disclosed
CN-1026048-C Use of solsonylurea compounds as herbicide TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1994-10-05 CN disclosed
CN-1018643-B Process for producing sulfonylurea compound TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1992-10-14 CN disclosed
CN-1059073-A Solsonylurea compounds is as the purposes of weed killer herbicide TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1992-03-04 CN disclosed
CN-87102123-A Sulfonylurea compounds, their preparation and their use as herbicides 1987-10-21 CN disclosed